Parmax Pharma Balance Sheet Annual

BSE: 540359 | NSE: - | ISIN: INE240T01014 | Sector: Biotechnology & Drugs

43.70 0.00 (0.00%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023
Period End Date	Mar 24	Mar 23
Cash Equivalents	0.05	0.41
Cashand Short Term Investments	0.05	0.41
Accounts Receivable- Trade Net	1.82	0.62
Total Receivables Net	3.32	2.82
Total Inventory	2.39	4.31
Other Current Assets Total	0.00	0.00
Total Current Assets	5.77	7.53
Property/ Plant/ Equipment Total- Net	9.38	9.50
Goodwill Net	0.00	0.00
Intangibles Net	0.00	0.00
Long Term Investments	0.00	0.00
Note Receivable- Long Term	0.18	0.19
Other Long Term Assets Total	0.00	0.40
Total Assets	15.33	17.61
Accounts Payable	7.39	4.66
Notes Payable/ Short Term Debt	0.00	0.00
Other Currentliabilities Total	1.82	2.47
Total Current Liabilities	9.21	7.14
Long Term Debt	5.91	4.48
Total Long Term Debt	5.91	4.48
Total Debt	5.91	4.48
Deferred Income Tax	0.14	0.14
Other Liabilities Total	0.00	0.00
Total Liabilities	15.26	11.76
Common Stock Total	4.45	4.45
Retained Earnings( Accumulated Deficit)	-4.38	1.40
Total Equity	0.07	5.86
Total Liabilities Shareholders' Equity	15.33	17.61
Total Common Shares Outstanding	3.74	3.74
Tangible Book Valueper Share Common Eq	0.02	1.57